Cinar, Bilge PiriTuncer, AsliBilge, NurayBunul, Sena DestanGozubatik Celik, Rabia GokcenCiftci, Eda DerleGenc, GencerKaraman, BedriyeKilic, Ahmet KasimSariteke, AlpSeferoglu, MeralTiftikcioglu, Bedile IremTunc, AbdulkadirUncu, GulgunYavas, IrfanYetkin, Mehmet FatihEfendi, HusnuSiva, Aksel2024-09-112024-09-1120231301-062Xhttps://tjn.org.tr/full-text/50/enghttp://hdl.handle.net/11727/12203Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions should be made by considering the disease process and the drugs used by the patient. Since vaccination can be performed at every stage of life, from childhood to adulthood, immune system activity, except where it is characteristic of the vaccine, should be reviewed in patients with MS. In this review, the applications of different vaccines in individuals with MS are discussed in two separate sections.enginfo:eu-repo/semantics/openAccessMultiple sclerosisvaccinationsafetyArticle2912110010508888000022-s2.0-851562044781309-2545